Dynamics of human adipose lipid turnover in health and metabolic disease

Nature

Volumn 478, Issue 7367, 2011, Pages 110-113

  Arner, Peter ^a   Bernard, Samuel ^b   Salehpour, Mehran ^c   Possnert, Göran ^c   Liebl, Jakob ^d   Steier, Peter ^d   Buchholz, Bruce A ^e   Eriksson, Mats ^a   Arner, Erik ^a   Hauner, Hans ^f   Skurk, Thomas ^f   Rydén, Mikael ^a   Frayn, Keith N ^g   Spalding, Kirsty L ^h  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITÉ DE LYON   (France)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF VIENNA   (Austria)

^e LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g CHURCHILL HOSPITAL   (United Kingdom)

^h KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; TRIACYLGLYCEROL;

BIOACCUMULATION; CARBON ISOTOPE; DISEASE PREVALENCE; FAT; LIPID; METABOLISM; OBESITY; OXIDATION; PATHOLOGY; POLLUTANT REMOVAL;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; DYSLIPIDEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INSULIN RESISTANCE; LIPID METABOLISM; LIPOLYSIS; METABOLIC DISORDER; OBESITY; OXIDATION; PRIORITY JOURNAL;

ADIPOCYTES; ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CELL AGING; CELL SIZE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA; DYSLIPIDEMIAS; HEALTH; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIPID METABOLISM; LIPOLYSIS; METABOLIC DISEASES; MIDDLE AGED; NUCLEAR WEAPONS; OBESITY; SUBCUTANEOUS FAT; TIME FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 80053927990     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10426     Document Type: Article

References (24)

1. Klein, R. A., Halliday, D.& Pittet, P. G. The use of 13-methyltetradecanoic acid as an indicator of adipose tissue turnover. Lipids 15, 572-579 (1980). (Pubitemid 11233175)
2. Márin, P., Oden, B. & Bjöntorp, P. Assimilation andmobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J. Clin. Endocrinol. Metab. 80, 239-243 (1995).
3. Márin, P., Rebuffe-Scrive, M. & Bjöntorp, P. Uptake of triglyceride fatty acids in adipose tissue in vivo in man. Eur. J. Clin. Invest. 20, 158-165 (1990).
4. Strawford, A., Antelo, F., Christiansen, M. & Hellerstein, M. K. Adipose tissue triglyceride turnover, de novo lipogenesis, and cell proliferation in humans measured with 2H2O. Am. J. Physiol. 286, E577-E588 (2004). (Pubitemid 38374955)
5. Nydal, R. & Lovseth, K. Distribution of radiocarbon fromnuclear tests. Nature 206, 1029-1031 (1965).
6. Levin, I.& Kromer, B. The tropospheric 14CO2 level in mid latitudes of the northern hemisphere (1959-2003). Radiocarbon 46, 1261-1272 (2004).
7. Spalding, K. L., Bhardwaj, R. D., Buchholz, B. A., Druid, H. & Frisen, J. Retrospective birth dating of cells in humans. Cell 122, 133-143 (2005). (Pubitemid 40977946)
8. Perl, S. et al. Significant human b-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. J. Clin. Endocrinol. Metab. 95, E234-E239 (2010).
9. Spalding, K. L. et al. Dynamics of fat cell turnover in humans. Nature 453, 783-787 (2008). (Pubitemid 351793777)
10. Bergmann, O. et al. Evidence for cardiomyocyte renewal in humans. Science 324, 98-102 (2009).
11. Bhardwaj, R. D. et al. Neocortical neurogenesis in humans is restricted to development. Proc. Natl Acad. Sci. USA 103, 12564-12568 (2006). (Pubitemid 44267298)
12. Bernard, S., Frisen, J.& Spalding, K. L. Amathematicalmodel for the interpretation of nuclear bomb test derived 14C incorporation in biological systems. Nucl. Instrum. Meth. B 268, 1295-1298 (2010).
13. Ekstedt, B. & Olivecrona, T. Uptake and release of fatty acids by rat adipose tissue: last in to first out? Lipids 5, 858-860 (1970).
14. Kerpel, S., Shafrir, E. & Shapiro, B. Mechanism of fatty acid assimilation in adipose tissue. Biochim. Biophys. Acta 46, 495-504 (1961).
15. Bjöntorp, P. Effects of age, sex, and clinical conditions on adipose tissue cellularity in man. Metabolism 23, 1091-1102 (1974).
16. Grundy, S. M. Chait, A & Brunzell, J. D. Familial combined hyperlipidemia workshop. Arterioscler. Thromb. Vasc. Biol. 7, 203-207 (1987). (Pubitemid 17061143)
17. Langin, D. et al. Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 54, 3190-3197 (2005). (Pubitemid 43334374)
18. Reynisdottir, S., Eriksson, M., Angelin, B. & Arner, P. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia. J. Clin. Invest. 95, 2161-2169 (1995).
19. van der Kallen, C. J. et al. Evidence of insulin resistant lipid metabolismin adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus. Atherosclerosis 164, 337-346 (2002).
20. Ayyobi, A. F. & Brunzell, J. D. Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia. Am. J. Cardiol. 92, 27-33 (2003).
21. Arner, P. Is familial combined hyperlipidaemia a genetic disorder of adipose tissue? Curr. Opin. Lipidol. 8, 89-94 (1997). (Pubitemid 27235068)
22. de Graaf, J., Veerkamp, M. J. & Stalenhoef, A. F. Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids. J. R. Soc. Med. 95 (suppl. 42), 46-53 (2002). (Pubitemid 34876142)
23. Blaak, E. E. et al. Fat oxidation before and after a high fat load in the obese insulinresistant state. J. Clin. Endocrinol. Metab. 91, 1462-1469 (2006).
24. Houmard, J. A. Intramuscular lipid oxidation and obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1111-R1116 (2008). (Pubitemid 351490629)